Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCMH.L Regulatory News (CMH)

  • There is currently no data for CMH

Director's Dealing

27 Mar 2007 14:54

Chamberlin & Hill PLC27 March 2007 CHAMBERLIN & HILL PLC 27 March 2007 Directors Dealing This notification is made in accordance with section 329 of the Companies Act1985 and Rule 17 of the AIM Rules. On 27 March 2007, the following awards over ordinary shares in the Company weremade under the rules of the Chamberlin & Hill Performance Share Plan and theChamberlin & Hill Share Option Plan to Directors of the Company, as follows: Chamberlin & Hill Performance Share Plan ("PSP") Director Number of Shares held under Award Tim Hair 49,995 Mark Bache 38,457 Adam Vicary 33,843 Under the PSP, awards are structured as nil-cost options granted under theEnterprise Management Incentives Scheme ("EMI Option") contained in Schedule 5to the Income Tax (Earnings and Pensions) Act 2003. No consideration was paid for the grant of the EMI Options. The vesting of an EMI Option is subject to the continued employment of theparticipant and the satisfaction of a performance condition set by theRemuneration Committee of the Company (see below). The EMI Options willnormally become exercisable in three equal tranches on each of the third, fourthand fifth anniversaries of the date of grant subject to the satisfaction of aperformance condition set by the Remuneration Committee of the Company. To theextent that an EMI Option or any part of an EMI Option becomes exercisable, itremains exercisable until the tenth anniversary of the date of grant. The proportion of awards that become exercisable under each tranche of the EMIOption varies on a straight line basis, from 25% to 100%, for average growth inunderlying fully diluted EPS of between 5% p.a. and 10% p.a. above RPI over theperiod between the grant and exercise dates. No options are exercisable ifgrowth is below this range. The base line for the purposes of this calculationis underlying fully diluted EPS, before exceptional and operating one-off costs,for the year ended 31 March 2007. Chamberlin & Hill Share Option Plan ("SOP") Director Number of Shares held under Option Tim Hair 202,282 Mark Bache 103,734 No consideration was paid for the grant of options under the SOP, which arestructured as market value options. The options will normally become exercisable in three equal tranches on each ofthe third, fourth and fifth anniversaries of the date of grant subject to thesatisfaction of performance conditions set by the Remuneration Committee of theCompany (see below). To the extent that an option or any part of an optionbecomes exercisable, it remains exercisable until the tenth anniversary of thedate of grant. The proportion of awards that become exercisable under each tranche of the SOPvaries on a straight line basis, from 25% to 100%, for average growth in TotalShareholder Return of between 15% p.a. and 25% p.a. over the period betweengrant and exercise dates, subject to achieving a minimum average growth inunderlying fully diluted EPS of 5% p.a. above RPI. No options are exercisable ifgrowth is below this range. The option price payable by each participant on the exercise of his option is192.8 pence. The rules of both the EMI Option and the SOP require that total awards, underthese and any other employee share option plan adopted by the company, must notexceed 10% of the Company's ordinary share capital over a 10 year period. Anyaward in excess of this limit would be subject to market purchase. Chamberlin & Hill Executive Share Option Scheme 1997 On 27 March 2007, Tim Hair surrendered for no consideration an option under theChamberlin & Hill Executive Share Option Scheme 1997 over 13,900 ordinary sharesin the Company. The option was granted on 21 June 2006 and had an exerciseprice per share of 215.5 pence. For further information, contact details are:Chamberlin & Hill plcTom Brown, Chairman 01922 707 100 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
8th Jul 20227:00 amRNSFull Year Trading Update and Notice of Results
8th Jun 20229:42 amRNSDirector/PDMR Shareholding
5th May 20221:13 pmRNSSale and Leaseback of RDC Property
25th Mar 20227:00 amRNSDirector/PDMR Shareholding
18th Mar 20222:30 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSHolding(s) in Company
21st Feb 20227:00 amRNSHolding(s) in Company
18th Feb 202210:30 amRNSResult of General Meeting and Total Voting Rights
2nd Feb 20227:00 amRNSProposed Placing and Subscription and Notice of GM
5th Jan 202212:15 pmRNSResult of AGM
4th Jan 20227:00 amRNSContract Award
21st Dec 20217:00 amRNSHalf-year Report
30th Nov 202111:01 amRNSFinal Results
16th Sep 20217:00 amRNSPublication of Audited Accounts and Trading Update
30th Jul 20217:00 amRNSHolding(s) in Company
9th Jul 20217:00 amRNSOperational Update
8th Jul 20217:00 amRNSHolding(s) in Company
8th Jun 20212:45 pmRNSResult of AGM
1st Jun 20217:00 amRNSDirectorate Change
28th May 20218:00 amRNSDirectorate Change
19th May 202111:05 amRNSSecond Price Monitoring Extn
19th May 202111:00 amRNSPrice Monitoring Extension
19th May 20219:05 amRNSSecond Price Monitoring Extn
19th May 20219:00 amRNSPrice Monitoring Extension
19th May 20217:00 amRNSOperational Update
14th May 20212:15 pmRNSChange of Accounting Reference Date
14th May 20217:00 amRNSGrant of Options
11th May 20214:41 pmRNSSecond Price Monitoring Extn
11th May 20214:36 pmRNSPrice Monitoring Extension
11th May 20212:05 pmRNSSecond Price Monitoring Extn
11th May 20212:00 pmRNSPrice Monitoring Extension
11th May 202111:05 amRNSSecond Price Monitoring Extn
11th May 202111:00 amRNSPrice Monitoring Extension
11th May 20219:05 amRNSSecond Price Monitoring Extn
11th May 20219:00 amRNSPrice Monitoring Extension
7th May 20217:00 amRNSDirectorate Change
5th May 20212:06 pmRNSSecond Price Monitoring Extn
5th May 20212:00 pmRNSPrice Monitoring Extension
27th Apr 20217:00 amRNSDirectorate Change
20th Apr 20214:10 pmEQSHardman & Co Research: Chamberlin (CMH): Getting back into shape
16th Apr 20217:30 amRNSRestoration - Chamberlin Plc
16th Apr 20217:00 amRNSHalf-year Report
16th Apr 20217:00 amRNSFinal Results
13th Apr 20215:04 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSFurther re Publication of Accounts
1st Apr 20217:00 amRNSTotal Voting Rights
30th Mar 20215:55 pmRNSHolding(s) in Company
30th Mar 20214:03 pmRNSHolding(s) in Company
30th Mar 20217:00 amRNSHolding(s) in Company
26th Mar 20217:00 amRNSPlacing, Subscription and Trading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.